{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:08:37Z","timestamp":1794960517615,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhenjiang key research and development plan","award":["SH2023050"],"award-info":[{"award-number":["SH2023050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04365-8","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T14:10:28Z","timestamp":1746799828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Human umbilical cord mesenchymal stem cell-derived exosomes repair IBD by activating the SIRT1-FXR pathway in macrophages"],"prefix":"10.1186","volume":"16","author":[{"given":"Mengjiao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxue","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis Atim","family":"Akanyibah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changkun","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5840-4436","authenticated-orcid":false,"given":"Fei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"4365_CR1","doi-asserted-by":"publisher","first-page":"733992","DOI":"10.3389\/fcimb.2022","volume":"12","author":"P Qiu","year":"2022","unstructured":"Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The gut microbiota in inflammatory bowel disease. Front Cell Infect Microbiol. 2022;12:733992. https:\/\/doi.org\/10.3389\/fcimb.2022.","journal-title":"Front Cell Infect Microbiol"},{"key":"4365_CR2","doi-asserted-by":"publisher","unstructured":"Dowdell AS, Colgan SP. Metabolic Host-Microbiota interactions in autophagy and the pathogenesis of inflammatory bowel disease (IBD). Pharmaceuticals (Basel). 2021;14(8). https:\/\/doi.org\/10.3390\/ph14080708.","DOI":"10.3390\/ph14080708"},{"issue":"4","key":"4365_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.pharep.2016.05.002","volume":"68","author":"JA Uranga","year":"2016","unstructured":"Uranga JA, L\u00f3pez-Miranda V, Lomb\u00f3 F, Abalo R. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease. Pharmacol Rep. 2016;68(4):816\u201326. https:\/\/doi.org\/10.1016\/j.pharep.2016.05.002.","journal-title":"Pharmacol Rep"},{"issue":"28","key":"4365_CR4","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.3748\/wjg.v26.i28.3998","volume":"26","author":"YA Ghouri","year":"2020","unstructured":"Ghouri YA, Tahan V, Shen B. Secondary causes of inflammatory bowel diseases. World J Gastroenterol. 2020;26(28):3998\u20134017. https:\/\/doi.org\/10.3748\/wjg.v26.i28.3998.","journal-title":"World J Gastroenterol"},{"key":"4365_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40364-019-0156-0","volume":"7","author":"P Lai","year":"2019","unstructured":"Lai P, Weng J, Guo L, Chen X, Du X. Novel insights into MSC-EVs therapy for immune diseases. Biomark Res. 2019;7:6. https:\/\/doi.org\/10.1186\/s40364-019-0156-0.","journal-title":"Biomark Res"},{"issue":"2","key":"4365_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871(2):455\u201368. https:\/\/doi.org\/10.1016\/j.bbcan.2019.04.004.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4365_CR7","doi-asserted-by":"publisher","unstructured":"Hade MD, Suire CN, Suo Z. Mesenchymal stem Cell-Derived exosomes: applications in regenerative medicine. Cells. 2021;10(8). https:\/\/doi.org\/10.3390\/cells10081959.","DOI":"10.3390\/cells10081959"},{"key":"4365_CR8","doi-asserted-by":"publisher","first-page":"110447","DOI":"10.1016\/j.intimp.2023.110447","volume":"121","author":"X Chang","year":"2023","unstructured":"Chang X, Song Y-H, Xia T, He Z-X, Zhao S-B, Wang Z-J, et al. Macrophage-derived exosomes promote intestinal mucosal barrier dysfunction in inflammatory bowel disease by regulating TMIGD1 via mircroRNA-223. Int Immunopharmacol. 2023;121:110447. https:\/\/doi.org\/10.1016\/j.intimp.2023.110447.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"4365_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.14336\/AD.2021.0601","volume":"12","author":"H Yu","year":"2021","unstructured":"Yu H, Yang X, Xiao X, Xu M, Yang Y, Xue C, Li X, Wang S, Zhao RC. Human adipose mesenchymal stem Cell-derived exosomes protect mice from DSS-Induced inflammatory bowel disease by promoting Intestinal-stem-cell and epithelial regeneration. Aging Dis. 2021;12(6):1423\u201337. https:\/\/doi.org\/10.14336\/AD.2021.0601.","journal-title":"Aging Dis"},{"key":"4365_CR10","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","volume":"19","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zhang H, Xiao D, Wei H, Chen Y. Farnesoid X receptor (FXR): structures and ligands. Comput Struct Biotechnol J. 2021;19:2148\u201359. https:\/\/doi.org\/10.1016\/j.csbj.2021.04.029.","journal-title":"Comput Struct Biotechnol J"},{"issue":"5","key":"4365_CR11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cmet.2009.09.009","volume":"10","author":"JK Kemper","year":"2009","unstructured":"Kemper JK, Xiao Z, Ponugoti B, Miao J, Fang S, Kanamaluru D, et al. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease States. Cell Metab. 2009;10(5):392\u2013404. https:\/\/doi.org\/10.1016\/j.cmet.2009.09.009.","journal-title":"Cell Metab"},{"issue":"3","key":"4365_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1074\/mcp.RA118.000817","volume":"18","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Liu F, Cheng Y, Xiao X-R, Hu D-D, Tang Y-M, et al. Celastrol protects from cholestatic liver injury through modulation of SIRT1-FXR signaling. Mol Cell Proteom. 2019;18(3):520\u201333. https:\/\/doi.org\/10.1074\/mcp.RA118.000817.","journal-title":"Mol Cell Proteom"},{"key":"4365_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fphar.2017.00260","volume":"8","author":"J Yang","year":"2017","unstructured":"Yang J, Sun L, Wang L, Hassan HM, Wang X, Hylemon PB, et al. Activation of Sirt1\/FXR signaling pathway attenuates Triptolide-Induced hepatotoxicity in rats. Front Pharmacol. 2017;8:260. https:\/\/doi.org\/10.3389\/fphar.2017.00260.","journal-title":"Front Pharmacol"},{"key":"4365_CR14","doi-asserted-by":"publisher","first-page":"111650","DOI":"10.1016\/j.mce.2022.111650","volume":"551","author":"S Fiorucci","year":"2022","unstructured":"Fiorucci S, Zampella A, Ricci P, Distrutti E, Biagioli M. Immunomodulatory functions of FXR. Mol Cell Endocrinol. 2022;551:111650. https:\/\/doi.org\/10.1016\/j.mce.2022.111650.","journal-title":"Mol Cell Endocrinol"},{"key":"4365_CR15","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173090.","journal-title":"Eur J Pharmacol"},{"key":"4365_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.trsl.2017.10.004","volume":"191","author":"C Li","year":"2018","unstructured":"Li C, Xu MM, Wang K, Adler AJ, Vella AT, Zhou B. Macrophage polarization and meta-inflammation. Transl Res. 2018;191:29\u201344. https:\/\/doi.org\/10.1016\/j.trsl.2017.10.004.","journal-title":"Transl Res"},{"issue":"1","key":"4365_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12964-023-01386-9","volume":"21","author":"K Zhang","year":"2023","unstructured":"Zhang K, Guo J, Yan W, Xu L. Macrophage polarization in inflammatory bowel disease. Cell Commun Signal. 2023;21(1):367. https:\/\/doi.org\/10.1186\/s12964-023-01386-9.","journal-title":"Cell Commun Signal"},{"issue":"9","key":"4365_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","volume":"16","author":"YR Na","year":"2019","unstructured":"Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16(9):531\u201343. https:\/\/doi.org\/10.1038\/s41575-019-0172-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"4365_CR19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.it.2022.10.003","volume":"43","author":"A Olona","year":"2022","unstructured":"Olona A, Leishman S, Anand PK. The NLRP3 inflammasome: regulation by metabolic signals. Trends Immunol. 2022;43(12):978\u201389. https:\/\/doi.org\/10.1016\/j.it.2022.10.003.","journal-title":"Trends Immunol"},{"issue":"4","key":"4365_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.bbrc.2015","volume":"467","author":"L Li","year":"2015","unstructured":"Li L, Zhang Q, Peng J, Jiang C, Zhang Y, Shen L, Dong J, Wang Y, Jiang Y. Activation of farnesoid X receptor downregulates monocyte chemoattractant protein-1 in murine macrophage. Biochem Biophys Res Commun. 2015;467(4):841\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2015.","journal-title":"Biochem Biophys Res Commun"},{"issue":"39","key":"4365_CR21","doi-asserted-by":"publisher","first-page":"14430","DOI":"10.3748\/wjg.v20.i39.14430","volume":"20","author":"J Yao","year":"2014","unstructured":"Yao J, Zhou C-S, Ma X, Fu B-Q, Tao L-S, Chen M, Xu Y-P. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation. World J Gastroenterol. 2014;20(39):14430\u201341. https:\/\/doi.org\/10.3748\/wjg.v20.i39.14430.","journal-title":"World J Gastroenterol"},{"key":"4365_CR22","doi-asserted-by":"publisher","unstructured":"Dong X, Qi M, Cai C, Zhu Y, Li Y, Coulter S, et al. Farnesoid X receptor mediates macrophage-intrinsic responses to suppress colitis-induced colon cancer progression. JCI Insight. 2024;9(2). https:\/\/doi.org\/10.1172\/jci.insight.170428.","DOI":"10.1172\/jci.insight.170428"},{"issue":"4","key":"4365_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.cmet.2017.03.014","volume":"25","author":"O Garcia-Irigoyen","year":"2017","unstructured":"Garcia-Irigoyen O, Moschetta A. A novel protective role for FXR against inflammasome activation and endotoxemia. Cell Metab. 2017;25(4):763\u20134. https:\/\/doi.org\/10.1016\/j.cmet.2017.03.014.","journal-title":"Cell Metab"},{"issue":"33","key":"4365_CR24","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.3748\/wjg.v23.i33.6016","volume":"23","author":"DD Eichele","year":"2017","unstructured":"Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our Understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol. 2017;23(33):6016\u201329. https:\/\/doi.org\/10.3748\/wjg.v23.i33.6016.","journal-title":"World J Gastroenterol"},{"key":"4365_CR25","doi-asserted-by":"publisher","unstructured":"Kim JJ, Shajib MS, Manocha MM, Khan WI. Investigating intestinal inflammation in DSS-induced model of IBD. J Vis Exp. 2012(60). https:\/\/doi.org\/10.3791\/3678","DOI":"10.3791\/3678"},{"issue":"11","key":"4365_CR26","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1002\/ijc.33386","volume":"148","author":"S Li","year":"2021","unstructured":"Li S, Yi M, Dong B, Tan X, Luo S, Wu K. The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction. Int J Cancer. 2021;148(11):2640\u201351. https:\/\/doi.org\/10.1002\/ijc.33386.","journal-title":"Int J Cancer"},{"key":"4365_CR27","doi-asserted-by":"publisher","first-page":"121369","DOI":"10.1016\/j.lfs.2023.121369","volume":"315","author":"M Dwivedi","year":"2023","unstructured":"Dwivedi M, Ghosh D, Saha A, Hasan S, Jindal D, Yadav H, Yadava A, Dwivedi M. Biochemistry of exosomes and their theranostic potential in human diseases. Life Sci. 2023;315:121369. https:\/\/doi.org\/10.1016\/j.lfs.2023.121369.","journal-title":"Life Sci"},{"issue":"1","key":"4365_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12951-023-01951-x","volume":"21","author":"Z Wei","year":"2023","unstructured":"Wei Z, Hang S, Wiredu Ocansey DK, Zhang Z, Wang B, Zhang X, Mao F. Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis. J Nanobiotechnol. 2023;21(1):188. https:\/\/doi.org\/10.1186\/s12951-023-01951-x.","journal-title":"J Nanobiotechnol"},{"key":"4365_CR29","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2147\/IJN.S453545","volume":"19","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Wang H, Liu Q, Zeng N, Fu G, Qiu Y, et al. Exosomes as powerful biomarkers in cancer: recent advances in isolation and detection techniques. Int J Nanomed. 2024;19:1923\u201349. https:\/\/doi.org\/10.2147\/IJN.S453545.","journal-title":"Int J Nanomed"},{"issue":"6","key":"4365_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22(6):845\u201354. https:\/\/doi.org\/10.1089\/scd.2012.0395.","journal-title":"Stem Cells Dev"},{"issue":"8","key":"4365_CR31","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.1021\/acsnano.7b07643","volume":"12","author":"Y Sun","year":"2018","unstructured":"Sun Y, Shi H, Yin S, Ji C, Zhang X, Zhang B, et al. Human mesenchymal stem cell derived exosomes alleviate type 2 diabetes mellitus by reversing peripheral insulin resistance and relieving \u03b2-Cell destruction. ACS Nano. 2018;12(8):7613\u201328. https:\/\/doi.org\/10.1021\/acsnano.7b07643.","journal-title":"ACS Nano"},{"issue":"1","key":"4365_CR32","doi-asserted-by":"publisher","first-page":"2221138","DOI":"10.1080\/0886022X.2023.2221138","volume":"45","author":"Y Wan","year":"2023","unstructured":"Wan Y, Yu Y, Yu C, Luo J, Wen S, Shen L, Wei G, Hua Y. Human umbilical cord mesenchymal stem cell exosomes alleviate acute kidney injury by inhibiting pyroptosis in rats and NRK-52E cells. Ren Fail. 2023;45(1):2221138. https:\/\/doi.org\/10.1080\/0886022X.2023.2221138.","journal-title":"Ren Fail"},{"issue":"51","key":"4365_CR33","doi-asserted-by":"publisher","first-page":"e2213041119","DOI":"10.1073\/pnas.2213041119","volume":"119","author":"T Fu","year":"2022","unstructured":"Fu T, Li Y, Oh TG, Cayabyab F, He N, Tang Q, et al. FXR mediates ILC-intrinsic responses to intestinal inflammation. Proc Natl Acad Sci U S A. 2022;119(51):e2213041119. https:\/\/doi.org\/10.1073\/pnas.2213041119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4365_CR34","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.bbrc.2017.06.129","volume":"490","author":"H-M Liu","year":"2017","unstructured":"Liu H-M, Liao J-F, Lee T-Y. Farnesoid X receptor agonist GW4064 ameliorates lipopolysaccharide-induced Ileocolitis through TLR4\/MyD88 pathway related mitochondrial dysfunction in mice. Biochem Biophys Res Commun. 2017;490(3):841\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.129.","journal-title":"Biochem Biophys Res Commun"},{"key":"4365_CR35","doi-asserted-by":"publisher","first-page":"154971","DOI":"10.1016\/j.phymed.2023","volume":"118","author":"T Qin","year":"2023","unstructured":"Qin T, Hasnat M, Wang Z, Hassan HM, Zhou Y, Yuan Z, Zhang W. Geniposide alleviated bile acid-associated NLRP3 inflammasome activation by regulating SIRT1\/FXR signaling in bile duct ligation-induced liver fibrosis. Phytomedicine. 2023;118:154971. https:\/\/doi.org\/10.1016\/j.phymed.2023.","journal-title":"Phytomedicine"},{"key":"4365_CR36","doi-asserted-by":"publisher","first-page":"111360","DOI":"10.1016\/j.intimp.2023.111360","volume":"128","author":"J Lai","year":"2024","unstructured":"Lai J, Li F, Li H, Huang R, Ma F, Gu X, et al. Melatonin alleviates necrotizing Enterocolitis by reducing bile acid levels through the SIRT1\/FXR signalling axis. Int Immunopharmacol. 2024;128:111360. https:\/\/doi.org\/10.1016\/j.intimp.2023.111360.","journal-title":"Int Immunopharmacol"},{"key":"4365_CR37","doi-asserted-by":"publisher","first-page":"109155","DOI":"10.1016\/jjnutbio.2022.109155","volume":"111","author":"S Wang","year":"2023","unstructured":"Wang S, Deng W, Li F, Xiang L, Lv P, Chen Y. Treatment with butyrate alleviates dextran sulfate sodium and Clostridium difficile-induced colitis by preventing activity of Th17 cells via regulation of SIRT1\/mTOR in mice. J Nutr Biochem. 2023;111:109155. https:\/\/doi.org\/10.1016\/jjnutbio.2022.109155.","journal-title":"J Nutr Biochem"},{"issue":"5","key":"4365_CR38","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/mi.2014.10","volume":"7","author":"T Akimova","year":"2014","unstructured":"Akimova T, Xiao H, Liu Y, Bhatti TR, Jiao J, Eruslanov E, et al. Targeting sirtuin-1 alleviates experimental autoimmune colitis by induction of Foxp3\u2009+\u2009T-regulatory cells. Mucosal Immunol. 2014;7(5):1209\u201320. https:\/\/doi.org\/10.1038\/mi.2014.10.","journal-title":"Mucosal Immunol"},{"issue":"11","key":"4365_CR39","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00109-023-02364-x","volume":"101","author":"T He","year":"2023","unstructured":"He T, Bai X, Li Y, Zhang D, Xu Z, Yang X, Hu D, Han J. Insufficient SIRT1 in macrophages promotes oxidative stress and inflammation during scarring. J Mol Med (Berl). 2023;101(11):1397\u2013407. https:\/\/doi.org\/10.1007\/s00109-023-02364-x.","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"4365_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/jcpe.13258","volume":"47","author":"J Zhang","year":"2020","unstructured":"Zhang J, Liu X, Wan C, Liu Y, Wang Y, Meng C, Zhang Y, Jiang C. NLRP3 inflammasome mediates M1 macrophage polarization and IL-1\u03b2 production in inflammatory root resorption. J Clin Periodontol. 2020;47(4):451\u201360. https:\/\/doi.org\/10.1111\/jcpe.13258.","journal-title":"J Clin Periodontol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04365-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T14:10:29Z","timestamp":1746799829000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04365-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4365"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04365-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics of animal research was approved by the Ethical Committee of Jiangsu University. [Approval title: Study on the role and mechanism of exosomes derived from hucMSC in regulating Neddylation in the repair of inflammatory bowel disease.] [Approval number: 2012258] (Approval date: 2020.3.31). The ethics of the human specimens in this study was approved by the Ethics Committee of Zhenjiang First People\u2019s Hospital. [Approval title: Study on the Mechanism of HucMSC-Ex regulating FXR Expression to inhibit Ferroptosis in Repairing IBD.] [Approval number: SQK-20240196-Y] (Approval date: 2024.9.27). And the Original Source (Procell) of THP-1 cells has confirmed initial ethical approval for the collection of human cells, and the donor has signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}